UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Trial of Galcanezumab in Prevention of Episodic Cluster Headache

The New England journal of medicine, 2019-07, Vol.381 (2), p.132-141

2019

Volltextzugriff (PDF)

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

Alzheimer's & dementia, 2016-02, Vol.12 (2), p.110-120

2016

Volltextzugriff (PDF)

Drug development in Alzheimer's disease: the path to 2025

Alzheimer's research & therapy, 2016-09, Vol.8 (1), p.39-39, Article 39

2016

Volltextzugriff (PDF)

On the path to 2025: understanding the Alzheimer's disease continuum

Alzheimer's research & therapy, 2017-08, Vol.9 (1), p.60-60, Article 60

2017

Volltextzugriff (PDF)

Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN

Cephalalgia, 2019-07, Vol.39 (8), p.957-966

2019

Volltextzugriff (PDF)

Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings

Current medical research and opinion, 2014-10, Vol.30 (10), p.2021-2032

2014

Volltextzugriff (PDF)

Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)

BMC neurology, 2019-08, Vol.19 (1), p.191-8, Article 191

2019

Volltextzugriff (PDF)

Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies

Neurology and therapy, 2020-12, Vol.9 (2), p.459-471

2020

Volltextzugriff (PDF)

Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study

Cephalalgia, 2021-03, Vol.41 (3), p.294-304

2021

Volltextzugriff (PDF)

Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study

The Journal of urology, 2016-03, Vol.195 (3), p.699-705

2016

Volltextzugriff (PDF)

Effects of Testosterone Level on Lower Urinary Tract Symptoms

American journal of men's health, 2016-09, Vol.10 (5), p.440-442

2016

Volltextzugriff (PDF)

Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study

Cephalalgia, 2022-01, Vol.42 (1), p.20-30

2022

Volltextzugriff (PDF)

Pain Freedom at 2 to 8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant

Headache, 2020-09, Vol.60 (8), p.1793-1796

2020

Volltextzugriff (PDF)

The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings

Headache, 2020-01, Vol.60 (1), p.178-189

2020

Volltextzugriff (PDF)

Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings

Neurology. Clinical practice, 2023-04, Vol.13 (2), p.e200127-e200127

2023

Volltextzugriff (PDF)

Measurement of testosterone: how important is a morning blood draw?

Current medical research and opinion, 2015-01, Vol.31 (10), p.1911-1914

2015

Volltextzugriff (PDF)

Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option

Current medical research and opinion, 2008-12, Vol.24 (12), p.3383-3392

2008

Volltextzugriff (PDF)

Alzheimer's disease progression by geographical region in a clinical trial setting

Alzheimer's research & therapy, 2015-06, Vol.7 (1), p.43-43, Article 43

2015

Volltextzugriff (PDF)

Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials

Alzheimer's research & therapy, 2015-06, Vol.7 (1), p.39-39, Article 39

2015

Volltextzugriff (PDF)

Developing good scientific publishing practices: one pharmaceutical company's perspective

Current medical research and opinion, 2010-06, Vol.26 (6), p.1249-1254

2010

Volltextzugriff (PDF)

Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass

Menopause (New York, N.Y.), 2012-01, Vol.19 (1), p.41

2012

Volltextzugriff (PDF)

Effect of Raloxifene on Cardiovascular Adverse Events in Postmenopausal Women With Osteoporosis

The American journal of cardiology, 2006-02, Vol.97 (4), p.520-527

2006

Volltextzugriff (PDF)

Cardiovascular effects of raloxifene: the arterial and venous systems

The American heart journal, 2004-05, Vol.147 (5), p.783-789

2004

Volltextzugriff (PDF)

Role of raloxifene in breast cancer prevention in postmenopausal women: Clinical evidence and potential mechanisms of action

Clinical Therapeutics, 2004-06, Vol.26 (6), p.830-840

2004

Volltextzugriff (PDF)

The Applicability of Half‐Mouth Examination to Periodontal Disease Assessment in Untreated Adult Populations

Journal of periodontology (1970), 2002-09, Vol.73 (9), p.975-981

2002

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

ThemaRisk Factors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(44)

Publikationsform

Sprache

Englisch
(51)
Japanisch
(8)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Trial of Galcanezumab in Prevention of Episodic Cluster Headache

Phase 3 solanezumab trials: Secondary outcomes in mild Alzheimer's disease patients

Drug development in Alzheimer's disease: the path to 2025

On the path to 2025: understanding the Alzheimer's disease continuum

Safety findings from Phase 3 lasmiditan studies for acute treatment of migraine: Results from SAMURAI and SPARTAN

Safety profile of semagacestat, a gamma-secretase inhibitor: IDENTITY trial findings

Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)

Improvement in Function after Lasmiditan Treatment: Post Hoc Analysis of Data from Phase 3 Studies

Randomized, controlled trial of lasmiditan over four migraine attacks: Findings from the CENTURION study

Effect of Testosterone Solution 2% on Testosterone Concentration, Sex Drive and Energy in Hypogonadal Men: Results of a Placebo Controlled Study

Effects of Testosterone Level on Lower Urinary Tract Symptoms

Lasmiditan efficacy in the acute treatment of migraine was independent of prior response to triptans: Findings from the CENTURION study

Pain Freedom at 2 to 8 Hours With Lasmiditan: A Comparison With Rimegepant and Ubrogepant

The Influence of Migraine on Driving: Current Understanding, Future Directions, and Potential Implications of Findings

Meaningful Clinical Changes in Alzheimer Disease Measured With the iADRS and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings

Measurement of testosterone: how important is a morning blood draw?

Efficacy and safety of tadalafil once daily: considerations for the practical application of a daily dosing option

Alzheimer's disease progression by geographical region in a clinical trial setting

Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer's disease clinical trials

Developing good scientific publishing practices: one pharmaceutical company's perspective

Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass

Effect of Raloxifene on Cardiovascular Adverse Events in Postmenopausal Women With Osteoporosis

Cardiovascular effects of raloxifene: the arterial and venous systems

Role of raloxifene in breast cancer prevention in postmenopausal women: Clinical evidence and potential mechanisms of action

The Applicability of Half‐Mouth Examination to Periodontal Disease Assessment in Untreated Adult Populations

Aktive Filter

Suchergebnisse filtern